# OnCo record imerge (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/imerge/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "imerge", "NCT02598661" ;
  schema:name "IMerge"@en ;
  schema:description "IMerge showed that imetelstat, a drug that blocks telomerase in the abnormal blood-forming cells, freed many people with lower-risk myelodysplastic syndromes from transfusions for months or years after erythropoietin had failed."@en ;
  schema:url <https://onco.cc/trials/imerge/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02598661> ;
  onco:status "positive" ;
  onco:tag "subtype-trials" ;
  onco:phase "2/3" ;
  onco:cancers <https://onco.cc/cancers/mds-lower-risk/>, <https://onco.cc/cancers/mds/> ;
  onco:drugs <https://onco.cc/drugs/imetelstat/> ;
  onco:companies <https://onco.cc/companies/geron/> ;
  onco:people <https://onco.cc/people/uwe-platzbecker/> .